In this webinar Nick Lench, PhD, Chief Scientific Officer at Congenica reviews the current state of knowledge regarding the genetics of COVID-19 and the potential application of pharmacogenetics to patient management and clinical trials. Dr Lench also describe the development of a Congenica COVID-19 application that enables the analysis of a patient’s genome data to identify clinically actionable DNA variants.
Learn more about the Congenica platform: [ Ссылка ]
Get in touch to learn more about our COVID-19 module: [ Ссылка ]
![⏳ [COUNTDOWN TIMER] - ⏱ Timer 10 seconds - 10 秒倒數 - Countdown 10 seconds](https://img.save4k.ru/pic/or55UctPW4w/mqdefault.jpg)